
Venture capital · Early stage · Est. 2021
Monograph Capital
Monograph Capital is a transatlantic life sciences investment firm with offices in London and San Francisco. It finds, funds and builds innovative therapeutics and healthcare companies.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Monograph Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Monograph Capital joined, from press and the firm’s own posts.
2 rounds in the last 12 months
Round sizes, Monograph Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Monograph Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Monograph Capital
Events where Monograph Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Monograph Capital is based in San Francisco, United States. It also has offices in London and Fort Worth.
In 2021.
2 fund vehicles are on public registers (SEC adviser filings), including MONOGRAPH CAPITAL PARTNERS II, L.P. and MONOGRAPH CAPITAL PARTNERS I, L.P.
Stages: Series A. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.
Monograph looks for leading scientific innovation and helps build strong companies across the Atlantic. It combines differentiated sourcing, long-standing pharma relationships, deep medical expertise and operating experience to turn promising science into treatments for patients. From the firm’s own website.
Monograph Capital lists 15 portfolio companies on its website, including Ascend Advanced Therapies, Autobahn, AviadoBio, Maxion Therapeutics and Nocion Therapeutics.
Firms whose websites list some of the same companies include Advent Life Sciences, 5AM Ventures and DCVC.
Know before Monograph Capital’s next round is announced.
PRO tracks Monograph Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.